These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7879180)

  • 61. [Effect of a platelet activating factor (PAF) antagonist on the hepatic afferent vascular occlusion].
    Fukuoka T; Nakajima Y; Matsumoto M; Nakano H; Shiratori T
    Nihon Geka Gakkai Zasshi; 1988 May; 89(5):788. PubMed ID: 3412312
    [No Abstract]   [Full Text] [Related]  

  • 62. A new platelet-activating factor antagonist (CV-6209) in preservation of heart and lung for transplantation.
    Qayumi KA; English JC; Feeley EJ; Poostizadeh A; Nikbakht-Sangari M
    Cardiovasc Drugs Ther; 1997 Dec; 11(6):777-85. PubMed ID: 9512873
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Importance of pH in renal preservation.
    Nghiem DD; Elkadi H; Southard JH
    Transplant Proc; 1988 Oct; 20(5):872-4. PubMed ID: 3055521
    [No Abstract]   [Full Text] [Related]  

  • 64. Interleukin 10 release during endotoxaemia in chimpanzees: role of platelet-activating factor and interleukin 6.
    van der Poll T; Jansen J; Levi M; ten Cate H; Hack CE; Aarden LA; ten Cate JW; van Deventer SJ
    Scand J Immunol; 1996 Jan; 43(1):122-5. PubMed ID: 8560191
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of unilateral renal ischemia-reperfusion upon the contralateral kidney.
    Fuzellier JF; Julia P; Haab F; Nochy D; Cambillau M; Carpentier A; Thibault P; Fabiani JN
    Transplant Proc; 1995 Aug; 27(4):2528-9. PubMed ID: 7652916
    [No Abstract]   [Full Text] [Related]  

  • 66. Urinary excretion of endothelin is elevated during hypothermic perfusion preservation in kidneys subjected to preretrieval warm ischemic injury.
    Inman SR; Osgood RW; Plott WK; Hubosky SG; Burns TE; Lewis RM
    Transplant Proc; 2000 Jun; 32(4):802-3. PubMed ID: 10856592
    [No Abstract]   [Full Text] [Related]  

  • 67. Agonist and antagonist of oxygen free radical.
    Ogata H; Midorikawa Y
    Can J Anaesth; 1990 May; 37(4 Pt 2):S104. PubMed ID: 2361243
    [No Abstract]   [Full Text] [Related]  

  • 68. Effect of warm ischemic time on kidney transplants.
    Toledo-Pereyra LH
    Contrib Nephrol; 1989; 71():129-37. PubMed ID: 2553334
    [No Abstract]   [Full Text] [Related]  

  • 69. Okadaic acid, an inhibitor of protein phosphatase, exerts a protective effect on ischemia-reperfusion injury in rat kidneys.
    Isotani S; Fujisawa M; Ishimura T; Arakawa S; Kamidono S
    Transplant Proc; 2002 Jun; 34(4):1345-8. PubMed ID: 12072356
    [No Abstract]   [Full Text] [Related]  

  • 70. Ex vivo resuscitation of kidneys following postmortem warm ischemia.
    Brasile L; Green E; Haisch C
    Transplant Proc; 1997 Dec; 29(8):3518-9. PubMed ID: 9414818
    [No Abstract]   [Full Text] [Related]  

  • 71. Expression of tissue factor in renal ischemic-reperfusion injury of the rat.
    Ushigome H; Yoshimura N; Sano H; Nakamura K; Oka T
    Transplant Proc; 1998 Nov; 30(7):3764-5. PubMed ID: 9838649
    [No Abstract]   [Full Text] [Related]  

  • 72. The role of platelet-activating factor antagonists in the prophylaxis of posttransplant acute tubular necrosis.
    GrinyĆ³ JM; Torras J; Valles J
    Ren Fail; 1996 May; 18(3):445-51. PubMed ID: 8827990
    [No Abstract]   [Full Text] [Related]  

  • 73. N-(acyloxyalkyl)pyridinium salts as soluble prodrugs of a potent platelet activating factor antagonist.
    Davidsen SK; Summers JB; Albert DH; Holms JH; Heyman HR; Magoc TJ; Conway RG; Rhein DA; Carter GW
    J Med Chem; 1994 Dec; 37(26):4423-9. PubMed ID: 7799395
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of platelet-activating factor antagonist CV-3988 in preservation of heart and lung for transplantation.
    Qayumi AK; Jamieson WR; Poostizadeh A
    Ann Thorac Surg; 1991 Oct; 52(4):1026-32. PubMed ID: 1929620
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Role of platelet-activating factor in acid-induced esophageal mucosal injury.
    Paterson WG; Kieffer CA; Feldman MJ; Miller DV; Morris GP
    Dig Dis Sci; 2007 Aug; 52(8):1861-6. PubMed ID: 17415649
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role of endogenous platelet-activating factor(PAF) in stress-induced hemorrhagic pancreatitis in rats.
    Kimura T; Furukawa M; Arita Y; Takano S; Yamaguchi H; Sumii T; Nawata H
    Gastroenterol Jpn; 1991 Feb; 26(1):100. PubMed ID: 2007454
    [No Abstract]   [Full Text] [Related]  

  • 77. The role of tissue factor in renal ischemic reperfusion injury by antisense oligodeoxynucleotide.
    Matsuyama M; Akioka K; Okamoto M; Kadotani Y; Ushigome H; Nakamura K; Yoshimura R; Ohmori Y; Yoshimura N
    Transplant Proc; 2002 Aug; 34(5):1475-6. PubMed ID: 12176446
    [No Abstract]   [Full Text] [Related]  

  • 78. Control of renal ischemic reperfusion injury by antisense oligodeoxynucleotide of tissue factor.
    Matsuyama M; Akioka K; Okamoto M; Kadotani Y; Nakamura K; Ushigome H; Ohmori Y; Yoshimura R; Nakatani T; Yoshimura N
    Transplant Proc; 2003 Feb; 35(1):103-4. PubMed ID: 12591326
    [No Abstract]   [Full Text] [Related]  

  • 79. [Bioelectrical activity and structural changes in the kidneys in the course of primary ischemia].
    Pirogov VA; Nosov AT; Nomirovich LI
    Fiziol Zh (1978); 1979; 25(5):558-65. PubMed ID: 527721
    [No Abstract]   [Full Text] [Related]  

  • 80. The three-kidney rat. Renal isografts and renal counterbalance.
    Klein TW; Gittes RF
    J Urol; 1973 Jan; 109(1):19-27. PubMed ID: 4567675
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.